Jun 2026 (Q2 FY26) — Aug 4, 2026
UL Solutions Q2 FY26 — Record Revenue and Strong Organic Growth
Read the full callUL Solutions earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 816 | +5.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 18.4 | +0.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 246 | +170.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
10 of 11 judged targets kept · 16 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Employee health & safety (EHS) software business divestiture closing | expected to close in the second quarter [2026] | Dec 2025 | The decline reflects the divestiture of our EHS software business, which closed on April 1. | Achieved |
| Full-year capital expenditures as % of revenue | approximately 7% to 8% of revenue | Dec 2025 | We now expect full year capital expenditures of approximately 8.5% of revenue, including the timing of our previously discussed investment in laboratory capacity and other growth opportunities to meet customer demand. | Revised Down |
| Full-year adjusted EBITDA margin | 26.5% to 27% | Dec 2025 | We continue to expect adjusted EBITDA margin improvement to approximately 27% for the full year, consistent with the guidance we raised last quarter | On Track |
1 of UL Solutions Inc.'s 27 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 24 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $75.4 on 17 Oct 2025 → $73.01. High $104.89 (6 May 2026), low $64.03 (18 Sept 2026).
Overview
Guidance
10 of 11 judged targets kept · 16 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Employee health & safety (EHS) software business divestiture closing | expected to close in the second quarter [2026] | Dec 2025 | The decline reflects the divestiture of our EHS software business, which closed on April 1. | Achieved |
| Full-year capital expenditures as % of revenue | approximately 7% to 8% of revenue | Dec 2025 | We now expect full year capital expenditures of approximately 8.5% of revenue, including the timing of our previously discussed investment in laboratory capacity and other growth opportunities to meet customer demand. | Revised Down |
| Full-year adjusted EBITDA margin | 26.5% to 27% | Dec 2025 | We continue to expect adjusted EBITDA margin improvement to approximately 27% for the full year, consistent with the guidance we raised last quarter | On Track |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 27 tracked commitments, with each call’s wording and source.
Call summaries
UL Solutions Q2 FY26 — Record Revenue and Strong Organic Growth
Read the full callEvery analysed call
Financials
Net profit, year on year: +170% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 731 | 739 | 705 | 776 | 783 | 789 | 758 | 816 |
| Operating profit | 130 | 115 | 109 | 139 | 156 | 118 | 138 | 150 |
| Operating margin | 17.8% | 15.6% | 15.5% | 17.9% | 19.9% | 15.0% | 18.2% | 18.4% |
| Other income | 0 | -10 | -3 | -4 | 0 | -4 | -1 | — |
| Interest | 14 | 13 | 12 | 10 | 10 | 9 | 8 | 5 |
| Profit before tax | 116 | 92 | 94 | 125 | 146 | 105 | 129 | 338 |
| Tax rate | 19.0% | 7.6% | 24.5% | 22.4% | 27.4% | 32.4% | 24.8% | 24.9% |
| Net profit | 88 | 81 | 67 | 91 | 100 | 67 | 92 | 246 |
| EPS ($ per share) | 0.44 | — | 0.34 | 0.45 | 0.50 | — | 0.46 | 1.22 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Equity capital | — | 0 | — | — |
| Reserves | — | 24 | 250 | 470 |
| Total liabilities | — | 2,058 | 1,869 | 1,627 |
| Fixed assets | — | 555 | 631 | 699 |
| Total assets | — | 2,736 | 2,800 | 2,921 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Cash from operations | 372 | 467 | 524 | 600 |
| Cash from investing | -238 | -175 | -234 | -204 |
| Cash from financing | -1,116 | -294 | -284 | -396 |
| Net cash flow | -1,006 | -7 | -17 | -3 |
| Capital expenditure | -164 | -215 | -237 | -197 |
| Free cash flow | 208 | 252 | 287 | 403 |
Industrial grew from 43% to 49% of revenue over the last two years.
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Industrial | 43% | 44% | 44% | — | 44% | — | 49% | 49% | — |
| Consumer | 44% | 42% | 43% | 44% | — | — | 42% | 44% | +6.5% |
| Risk Compliance Software | — | — | — | — | — | — | 9% | 6% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
115 filings between Dec 5, 2025 and Oct 8, 2026.
Purchases
$3.0K
2 purchases by 2 insiders
Sales
$1.13B
26 sales by 6 insiders
81% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 6 gifts, 2 conversions, 2 L filings.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| ULSE Inc. | — | $1.12B | Dec 19, 2025 |
| Scanlon Jennifer F. | — | $7.65M | Oct 8, 2026 |
| Schjotz Gitte | — | $2.99M | Jun 3, 2026 |
| Uggetti Alberto | — | $844.2K | May 28, 2026 |
| Hecker Friedrich | — | $408.2K | May 21, 2026 |
| PEPPING KAREN K | — | $70.9K | Jun 9, 2026 |
| Genovesi John A | $2.3K | — | Dec 8, 2025 |
| Hancock Lynn H | $623 | — | Dec 8, 2025 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 12,500 | $876.0K |
| Sep 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 2,005 | $149.2K |
| Sep 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 10,495 | $771.6K |
| Aug 6, 2026 | Shannon James M Director | Gift | 600 | $0 |
| Aug 3, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 5,590 | $519.2K |
| Aug 3, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 3,629 | $330.3K |
| Aug 3, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 3,281 | $301.5K |
| Jul 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 3,600 | $356.6K |
| Jul 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 4,800 | $470.0K |
| Jul 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 2,600 | $262.7K |
| Jul 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 1,200 | $120.4K |
| Jul 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 300 | $30.5K |
| Jun 9, 2026 | PEPPING KAREN K Senior VP & CAO | Sale 10b5-1 plan | 725 | $70.9K |
| Jun 3, 2026 | Schjotz Gitte See Remarks | Sale 10b5-1 plan | 9,865 | $956.7K |
| Jun 2, 2026 | Schjotz Gitte See Remarks | Sale 10b5-1 plan | 12,015 | $1.20M |
| Jun 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 4,995 | $502.5K |
| Jun 1, 2026 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 plan | 7,505 | $747.5K |
| May 29, 2026 | Robinson Ryan D Executive VP & CFO | Gift | 29,268 | $0 |
| May 29, 2026 | Robinson Ryan D Executive VP & CFO | Gift | 29,268 | $0 |
| May 28, 2026 | Uggetti Alberto EVP & CCO | Sale 10b5-1 plan | 2,345 | $234.2K |
| May 21, 2026 | Hecker Friedrich Director | Sale | 4,000 | $408.2K |
| May 20, 2026 | DOLLIVE JAMES P Director | Option exercise | 2,805 | — |
| May 20, 2026 | THAMAN MICHAEL H Director | Option exercise | 2,805 | — |
| May 20, 2026 | Kini Vikram Director | Option exercise | 2,805 | — |
| May 20, 2026 | Hecker Friedrich Director | Tax withheld | 1,266 | $129.1K |
| May 20, 2026 | Hecker Friedrich Director | Option exercise | 2,805 | — |
| May 15, 2026 | Scanlon Jennifer F. President and CEO | Gift | 11,242 | $0 |
| May 11, 2026 | Uggetti Alberto EVP & CCO | Sale | 6,100 | $610.0K |
| May 7, 2026 | Schjotz Gitte See Remarks | Option exercise | 22,340 | $633.1K |
| May 7, 2026 | Schjotz Gitte See Remarks | Sale | 8,000 | $831.6K |
| May 7, 2026 | Schjotz Gitte See Remarks | Tax withheld | 6,370 | $633.2K |
| May 1, 2026 | Scanlon Jennifer F. President and CEO | Tax withheld | 9,486 | $868.9K |
| May 1, 2026 | Uggetti Alberto EVP & CCO | Tax withheld | 268 | $23.6K |
| May 1, 2026 | Scanlon Jennifer F. President and CEO | Option exercise | 21,413 | — |
| May 1, 2026 | Robinson Ryan D Executive VP & CFO | Tax withheld | 2,154 | $197.3K |
| May 1, 2026 | Robinson Ryan D Executive VP & CFO | Option exercise | 4,862 | — |
| May 1, 2026 | Schjotz Gitte See Remarks | Option exercise | 2,755 | — |
| May 1, 2026 | PEPPING KAREN K Senior VP & CAO | Option exercise | 725 | — |
| May 1, 2026 | Hancock Lynn H See Remarks | Tax withheld | 573 | $52.5K |
| May 1, 2026 | Hancock Lynn H See Remarks | Option exercise | 1,293 | — |
| May 1, 2026 | Genovesi John A See Remarks | Tax withheld | 765 | $70.1K |
| May 1, 2026 | Genovesi John A See Remarks | Option exercise | 1,943 | — |
| May 1, 2026 | Chapin Linda S EVP & CHRO | Option exercise | 1,456 | — |
| May 1, 2026 | Uggetti Alberto EVP & CCO | Option exercise | 1,132 | — |
| May 1, 2026 | D'Angelo Scott EVP, CLO & Corporate Secy | Tax withheld | 351 | $32.2K |
| May 1, 2026 | PEPPING KAREN K Senior VP & CAO | Tax withheld | 271 | $24.8K |
| May 1, 2026 | D'Angelo Scott EVP, CLO & Corporate Secy | Option exercise | 1,196 | — |
| May 1, 2026 | D'Angelo Scott EVP, CLO & Corporate Secy | Tax withheld | 842 | $77.1K |
| May 1, 2026 | D'Angelo Scott EVP, CLO & Corporate Secy | Option exercise | 2,873 | — |
| May 1, 2026 | Chapin Linda S EVP & CHRO | Tax withheld | 611 | $56.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow UL Solutions Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading